Shanghai Haini Pharmaceutical Co., Ltd.   Report issue

For profit Phase 1
Founded: Shanghai China (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2016
NCT02974439
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now